0.55T MAGNETOM Free.Max: Case Study to Evaluate MRI Sequences for Various Body Areas and Organs in Healthy Volunteers and Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024793

Enrollment

140

Registered

2021-03-30

Start date

2021-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers and patients

Interventions

Group 1: One-time MRI imaging at the 0.55T scanner FreeMax for health volunteers Group 2: One-time MRI imaging at the 0.55T scanner FreeMax for patients

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Phase A (healthy volunteers) • Written informed consent • Age = 18 years • Weight <200kg • Medical certificate for MR-suitability (with regard to MR safety) Phase B (patients with MR-MR double examination) • Examination at the 1.5T MRI AVANTO and at the Free.Max (MAGNETOM System) according to clinical indication • Age =18 years • Written informed consent • Weight <200kg

Exclusion criteria

Exclusion criteria: Identical for Phase A and B • Lack of patient condition for MRI examination, e.g. metal implant or pacemaker • Exclusion of pregnant and breast-feeding women • Age < 18 years • Lack of informed consent

Design outcomes

Primary

Measure	Time frame
Evaluation of MR sequences of the 0.55 T MAGNETOM Free.Max compared to clinically established MRI scanner. For this purpose, various body regions and organs of healthy volunteers and patients will be scanned.	—

Secondary

Measure	Time frame
evaluation of patient comfort.	—

Countries

Switzerland

Contacts

Public ContactJens Bremerich

Universitätsspital Basel

jens.bremerich@usb.ch0041613287342

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026